Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BIOLIFE SOLUTIONS INCBLFS · Entity 4614 | Director | March 08, 2024 | March 13, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BIOLIFE SOLUTIONS INC
Report date March 08, 2024 · Filed March 13, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 43,953 |
Reported balance
After 2024-03-08 transaction · row 1
1 source rowRow 1 · 2024-03-08 · Grant · Acquired 11,264 · Balance 43,953 F1: The restricted stock was granted pursuant to the BioLife Solutions 2023 Performance Incentive Plan (the "2023 Plan") and fully vests on the first anniversary of the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: The restricted stock was granted pursuant to the BioLife Solutions 2023 Performance Incentive Plan (the "2023 Plan") and fully vests on the first anniversary of the grant date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 08, 2024 Filed Mar 13, 2024 01:42 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | GrantCommon Stock | 11,264 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-24-010740 · wk-form4_1710294104.xml · nonDerivative · entry 1 Schick Joseph C · CIK 0001592238 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,953 F1 · price: The restricted stock was granted pursuant to the BioLife Solutions 2023 Performance Incentive Plan (the "2023 Plan") and fully vests on the first anniversary of the grant date. Read SEC document |
| November 01, 2023 Filed Nov 3, 2023 21:10 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | GrantCommon Stock | 608 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-036782 · wk-form4_1699045830.xml · nonDerivative · entry 1 Schick Joseph C · CIK 0001592238 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,689 F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash director fees at the last closing price as of the date of grant. Read SEC document |
| October 01, 2023 Filed Oct 10, 2023 21:27 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | GrantCommon Stock | 445 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-034208 · wk-form4_1696973227.xml · nonDerivative · entry 1 Schick Joseph C · CIK 0001592238 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,081 F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash director fees at the last closing price as of the date of grant. Read SEC document |
| January 03, 2023 Filed Jan 19, 2023 00:01 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | GrantCommon Stock | 10,187 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-23-001267 · rdgdoc.xml · nonDerivative · entry 1 Schick Joseph C · CIK 0001592238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,636 F1 · price: The restricted stock was granted pursuant to the BioLife Solutions 2013 Performance Incentive Plan (the "Plan") and fully vests on the first anniversary of the grant date. Read SEC document |
| November 16, 2022 Filed Nov 18, 2022 01:00 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | SaleCommon Stock | 3,000 | $23.85 | $71,550.00 |
DisclosureSEC source: 0001437749-22-027683 · rdgdoc.xml · nonDerivative · entry 1 Schick Joseph C · CIK 0001592238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,449 Read SEC document |
| August 01, 2022 Filed Aug 3, 2022 00:02 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | GrantCommon Stock | 311 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-22-018515 · rdgdoc.xml · nonDerivative · entry 1 Schick Joseph C · CIK 0001592238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,449 F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of directors fees at the last closing price as of the date of grant. Read SEC document |
| July 01, 2022 Filed Jul 7, 2022 00:01 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | GrantCommon Stock | 409 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-22-016766 · rdgdoc.xml · nonDerivative · entry 1 Schick Joseph C · CIK 0001592238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,138 F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of directors fees at the last closing price as of the date of grant. Read SEC document |
| June 01, 2022 Filed Jun 4, 2022 00:03 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | GrantCommon Stock | 374 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-22-014309 · rdgdoc.xml · nonDerivative · entry 1 Schick Joseph C · CIK 0001592238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,729 F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of directors fees at the last closing price as of the date of grant. Read SEC document |
| May 06, 2022 Filed May 11, 2022 00:01 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | GrantCommon Stock | 14,730 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-22-011802 · rdgdoc.xml · nonDerivative · entry 1 Schick Joseph C · CIK 0001592238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,355 F1 · price: The restricted stock was granted pursuant to the BioLife Solutions 2013 Performance Incentive Plan (the "Plan") and fully vests on the first anniversary of the grant date. Read SEC document |
| October 07, 2021 Filed Oct 13, 2021 00:00 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | SaleCommon Stock | 2,000 | $39.96 | $79,920.00 |
DisclosureSEC source: 0001437749-21-023553 · rdgdoc.xml · nonDerivative · entry 3 Schick Joseph C · CIK 0001592238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,625 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.87 to $40.08, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| October 07, 2021 Filed Oct 13, 2021 00:00 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | SaleCommon Stock | 625 | $40.08 | $25,050.00 |
DisclosureSEC source: 0001437749-21-023553 · rdgdoc.xml · nonDerivative · entry 2 Schick Joseph C · CIK 0001592238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,625 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.0801 to $40.0835, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| October 07, 2021 Filed Oct 13, 2021 00:00 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | SaleCommon Stock | 625 | $40.28 | $25,175.00 |
DisclosureSEC source: 0001437749-21-023553 · rdgdoc.xml · nonDerivative · entry 1 Schick Joseph C · CIK 0001592238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,250 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| August 25, 2021 Filed Aug 28, 2021 00:01 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | SaleCommon Stock | 1,875 | $52.54 | $98,512.50 |
DisclosureSEC source: 0001437749-21-021108 · rdgdoc.xml · nonDerivative · entry 1 Schick Joseph C · CIK 0001592238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,875 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.53 to $52.58, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| August 18, 2021 Filed Aug 20, 2021 00:00 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | SaleCommon Stock | 625 | $44.11 | $27,568.75 |
DisclosureSEC source: 0001437749-21-020557 · rdgdoc.xml · nonDerivative · entry 1 Schick Joseph C · CIK 0001592238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,750 Read SEC document |
| July 12, 2021 Filed Jul 15, 2021 00:01 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | GrantCommon Stock | 5,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-21-016943 · rdgdoc.xml · nonDerivative · entry 1 Schick Joseph C · CIK 0001592238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,375 F1 · price: The restricted stock was granted pursuant to the BioLife Solutions 2013 Performance Incentive Plan and vests on the twelve-month anniversary of the grant date. Read SEC document |
| May 24, 2021 Filed May 27, 2021 00:01 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | SaleCommon Stock | 1,250 | $31.61 | $39,512.50 |
DisclosureSEC source: 0001437749-21-013450 · rdgdoc.xml · nonDerivative · entry 1 Schick Joseph C · CIK 0001592238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,375 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.61 to $31.63, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| November 12, 2020 Filed Nov 17, 2020 02:21 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $1.90 | $0.00 |
DisclosureSEC source: 0001437749-20-024046 · rdgdoc.xml · derivative · entry 3 Schick Joseph C · CIK 0001592238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2026-03-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The options vested 100% on the first anniversary of the grant date. Read SEC document |
| November 12, 2020 Filed Nov 17, 2020 02:21 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | SaleCommon Stock | 6,250 | $33.12 | $207,000.00 |
DisclosureSEC source: 0001437749-20-024046 · rdgdoc.xml · nonDerivative · entry 2 Schick Joseph C · CIK 0001592238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,625 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.05 to $33.30, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| November 12, 2020 Filed Nov 17, 2020 02:21 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionCommon Stock | 5,000 | $1.90 | $9,500.00 |
DisclosureSEC source: 0001437749-20-024046 · rdgdoc.xml · nonDerivative · entry 1 Schick Joseph C · CIK 0001592238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,875 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 05, 2020 Filed Oct 8, 2020 00:31 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | GrantCommon Stock | 5,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-20-020871 · rdgdoc.xml · nonDerivative · entry 1 Schick Joseph C · CIK 0001592238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,875 F1 · price: The restricted stock was granted pursuant to the BioLife Solutions 2013 Performance Incentive Plan and vests on the twelve-month anniversary of the grant date. Read SEC document |
| September 18, 2019 Filed Sep 19, 2019 00:01 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionEmployee Stock Option · Derivative | 3,287 | $0.00 Strike: $1.90 | $0.00 |
DisclosureSEC source: 0001437749-19-018657 · rdgdoc.xml · derivative · entry 6 Schick Joseph C · CIK 0001592238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 3,287 shares Expires 2025-03-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 18, 2019 Filed Sep 19, 2019 00:01 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | SaleCommon Stock | 3,287 | $21.00 | $69,027.00 |
DisclosureSEC source: 0001437749-19-018657 · rdgdoc.xml · nonDerivative · entry 4 Schick Joseph C · CIK 0001592238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,875 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2019. Read SEC document |
| September 18, 2019 Filed Sep 19, 2019 00:01 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionCommon Stock | 3,287 | $1.90 | $6,245.30 |
DisclosureSEC source: 0001437749-19-018657 · rdgdoc.xml · nonDerivative · entry 3 Schick Joseph C · CIK 0001592238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,162 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 17, 2019 Filed Sep 19, 2019 00:01 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionEmployee Stock Option · Derivative | 1,713 | $0.00 Strike: $1.90 | $0.00 |
DisclosureSEC source: 0001437749-19-018657 · rdgdoc.xml · derivative · entry 5 Schick Joseph C · CIK 0001592238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,287 Underlying: Common Stock · 1,713 shares Expires 2025-03-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 17, 2019 Filed Sep 19, 2019 00:01 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | SaleCommon Stock | 1,713 | $21.00 | $35,973.00 |
DisclosureSEC source: 0001437749-19-018657 · rdgdoc.xml · nonDerivative · entry 2 Schick Joseph C · CIK 0001592238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,875 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2019. Read SEC document |
| September 17, 2019 Filed Sep 19, 2019 00:01 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionCommon Stock | 1,713 | $1.90 | $3,254.70 |
DisclosureSEC source: 0001437749-19-018657 · rdgdoc.xml · nonDerivative · entry 1 Schick Joseph C · CIK 0001592238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,588 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 16, 2019 Filed May 18, 2019 00:03 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionEmployee Stock Option · Derivative | 2,900 | $0.00 Strike: $2.06 | $0.00 |
DisclosureSEC source: 0001437749-19-010418 · rdgdoc.xml · derivative · entry 6 Schick Joseph C · CIK 0001592238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,900 shares Expires 2025-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 16, 2019 Filed May 18, 2019 00:03 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | SaleCommon Stock | 2,900 | $18.01 | $52,229.00 |
DisclosureSEC source: 0001437749-19-010418 · rdgdoc.xml · nonDerivative · entry 4 Schick Joseph C · CIK 0001592238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,875 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2019. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.00 to $18.03, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| May 16, 2019 Filed May 18, 2019 00:03 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionCommon Stock | 2,900 | $2.06 | $5,974.00 |
DisclosureSEC source: 0001437749-19-010418 · rdgdoc.xml · nonDerivative · entry 3 Schick Joseph C · CIK 0001592238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,775 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 15, 2019 Filed May 18, 2019 00:03 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionEmployee Stock Option · Derivative | 1,900 | $0.00 Strike: $2.06 | $0.00 |
DisclosureSEC source: 0001437749-19-010418 · rdgdoc.xml · derivative · entry 5 Schick Joseph C · CIK 0001592238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,900 Underlying: Common Stock · 1,900 shares Expires 2025-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 15, 2019 Filed May 18, 2019 00:03 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | SaleCommon Stock | 1,900 | $18.00 | $34,200.00 |
DisclosureSEC source: 0001437749-19-010418 · rdgdoc.xml · nonDerivative · entry 2 Schick Joseph C · CIK 0001592238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,875 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2019. Read SEC document |
| May 15, 2019 Filed May 18, 2019 00:03 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionCommon Stock | 1,900 | $2.06 | $3,914.00 |
DisclosureSEC source: 0001437749-19-010418 · rdgdoc.xml · nonDerivative · entry 1 Schick Joseph C · CIK 0001592238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,775 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 07, 2019 Filed May 9, 2019 23:00 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionEmployee Stock Option · Derivative | 200 | $0.00 Strike: $2.06 | $0.00 |
DisclosureSEC source: 0001437749-19-009343 · rdgdoc.xml · derivative · entry 3 Schick Joseph C · CIK 0001592238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,800 Underlying: Common Stock · 200 shares Expires 2025-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 07, 2019 Filed May 9, 2019 23:00 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | SaleCommon Stock | 200 | $18.00 | $3,600.00 |
DisclosureSEC source: 0001437749-19-009343 · rdgdoc.xml · nonDerivative · entry 2 Schick Joseph C · CIK 0001592238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,875 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2019. Read SEC document |
| May 07, 2019 Filed May 9, 2019 23:00 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionCommon Stock | 200 | $2.06 | $412.00 |
DisclosureSEC source: 0001437749-19-009343 · rdgdoc.xml · nonDerivative · entry 1 Schick Joseph C · CIK 0001592238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,075 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 16, 2019 Filed Apr 18, 2019 00:16 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | SaleCommon Stock | 3,125 | $17.47 | $54,593.75 |
DisclosureSEC source: 0001437749-19-007471 · rdgdoc.xml · nonDerivative · entry 4 Schick Joseph C · CIK 0001592238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,875 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2019. Read SEC document |
| April 15, 2019 Filed Apr 18, 2019 00:16 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionEmployee Stock Option · Derivative | 10,000 | $0.00 Strike: $2.06 | $0.00 |
DisclosureSEC source: 0001437749-19-007471 · rdgdoc.xml · derivative · entry 6 Schick Joseph C · CIK 0001592238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 10,000 shares Expires 2025-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 15, 2019 Filed Apr 18, 2019 00:16 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionEmployee Stock Option · Derivative | 8,928 | $0.00 Strike: $8.51 | $0.00 |
DisclosureSEC source: 0001437749-19-007471 · rdgdoc.xml · derivative · entry 5 Schick Joseph C · CIK 0001592238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,928 shares Expires 2023-12-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 15, 2019 Filed Apr 18, 2019 00:16 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | SaleCommon Stock | 18,928 | $17.05 | $322,722.40 |
DisclosureSEC source: 0001437749-19-007471 · rdgdoc.xml · nonDerivative · entry 3 Schick Joseph C · CIK 0001592238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2019. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.90 to $17.56, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| April 15, 2019 Filed Apr 18, 2019 00:16 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionCommon Stock | 10,000 | $2.06 | $20,600.00 |
DisclosureSEC source: 0001437749-19-007471 · rdgdoc.xml · nonDerivative · entry 2 Schick Joseph C · CIK 0001592238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,928 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 15, 2019 Filed Apr 18, 2019 00:16 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionCommon Stock | 8,928 | $8.51 | $75,977.28 |
DisclosureSEC source: 0001437749-19-007471 · rdgdoc.xml · nonDerivative · entry 1 Schick Joseph C · CIK 0001592238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,928 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 24, 2018 Filed Aug 24, 2018 21:37 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | SaleCommon Stock | 4,765 | $25.96 | $123,688.92 |
DisclosureSEC source: 0001437749-18-016138 · rdgdoc.xml · nonDerivative · entry 1 Schick Joseph C · CIK 0001592238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Read SEC document |
| June 01, 2018 Filed Jun 6, 2018 00:07 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | SaleCommon Stock | 6,858 | $10.07 | $69,058.69 |
DisclosureSEC source: 0001437749-18-011309 · rdgdoc.xml · nonDerivative · entry 1 Schick Joseph C · CIK 0001592238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,765 Read SEC document |
| January 03, 2018 Filed Jan 4, 2018 02:27 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | GrantCommon Stock | 1,042 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001144204-18-000662 · tv482647_4.xml · nonDerivative · entry 2 Schick Joseph C · CIK 0001592238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,623 F2 · price: The shares of common stock were issued to the reporting person pursuant to the BioLife Solutions 2013 Performance Incentive Plan in lieu of receiving $6,250 of director fees for the quarter at a price per share based upon the closing stock price of the issuer's common stock on the last day of the quarter. Read SEC document |
| January 01, 2018 Filed Jan 4, 2018 02:27 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | GrantCommon Stock | 10,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001144204-18-000662 · tv482647_4.xml · nonDerivative · entry 1 Schick Joseph C · CIK 0001592238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,581 F1 · shares: The restricted stock was granted pursuant to the BioLife Solutions 2013 Performance Incentive Plan and vests 25% on the first anniversary of the grant date and thereafter quarterly, in 12 equal quarterly installments. F1 · price: The restricted stock was granted pursuant to the BioLife Solutions 2013 Performance Incentive Plan and vests 25% on the first anniversary of the grant date and thereafter quarterly, in 12 equal quarterly installments. Read SEC document |
| October 03, 2017 Filed Oct 3, 2017 20:04 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | GrantCommon Stock | 1,108 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001144204-17-051152 · v476389_4.xml · nonDerivative · entry 1 Schick Joseph C · CIK 0001592238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,581 F1 · price: The shares of common stock were issued to the reporting person pursuant to the BioLife Solutions 2013 Performance Incentive Plan in lieu of receiving $6,250 of director fees for the quarter at a price per share based upon the closing stock price of the issuer's common stock on the last day of the quarter. Read SEC document |
| July 06, 2017 Filed Jul 7, 2017 20:04 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | GrantCommon Stock | 2,615 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001144204-17-036096 · v470495_4.xml · nonDerivative · entry 1 Schick Joseph C · CIK 0001592238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,473 F1 · price: The shares of common stock were issued to the reporting person pursuant to the BioLife Solutions 2013 Performance Incentive Plan in lieu of receiving $6,250 of director fees for the quarter at a price per share based upon the closing stock price of the issuer's common stock on the last day of the quarter. Read SEC document |
| April 03, 2017 Filed Apr 6, 2017 01:55 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | GrantCommon Stock | 2,976 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001144204-17-019306 · v463692_4.xml · nonDerivative · entry 1 Schick Joseph C · CIK 0001592238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,858 F1 · price: The shares of common stock were issued to the reporting person pursuant to the BioLife Solutions 2013 Performance Incentive Plan in lieu of receiving $6,250 of director fees for the quarter. Read SEC document |
| January 13, 2017 Filed Jan 19, 2017 00:36 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | GrantCommon Stock | 3,882 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001144204-17-002794 · v456516_4.xml · nonDerivative · entry 1 Schick Joseph C · CIK 0001592238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,882 F1 · price: The shares of common stock were issued to the reporting person pursuant to the BioLife Solutions 2013 Performance Incentive Plan in lieu of receiving $6,250 of director fees for the quarter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.